How Far Can 12 Straight Wins Take a Trader Who Is Still Down $22.8 Million?

BeInCrypto2026/10/05 11:51

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Machi Big Brother has won 12 consecutive trades over the past week, earning $2.14 million, according to Lookonchain. The gains all trace back to one token. Behind the streak sits a Hyperliquid account with a long losing record and about $151 million in open longs. Inside the Week That Paid Machi Big Brother $2.14 Million Every win in the streak came on Pump.fun (PUMP). Lookonchain first flagged the run on October 2, after 10 straight PUMP wins over 5 days. Those trades had made $1.34 million, so the 2 latest wins brought the total to $2.14 million. Hyperbot shows 4 open perpetual positions on his account, all of them long. The largest is 33,800 Ethereum (ETH) at 25x leverage, worth $91.98 million. Machi Big Brother Open Positions. Source: Hyperbot Bitcoin (BTC) follows at $39.26 million across 455 BTC, with 40x leverage. He also holds 164,500 Hyperliquid (HYPE) at 10x, worth $15.36 million. His PUMP long has grown to 700 million tokens, worth $4.48 million. Lookonchains post put that position at 425 million tokens. The PUMP long is also the only one in the red, down about $50,557. The 3 larger longs, meanwhile, carry about $2.3 million in combined unrealized profit. However, holding the ETH position has already cost him $1.26 million in funding payments. Hyperbot places his ETH liquidation price at $2,452.53 and his BTC liquidation price at $66,456.5. His HYPE long would face liquidation at $36.39. Over the past week, the tracker records an 80% win rate across 15 closed positions. Hyperbot puts his equity at $12.2 million and his overall leverage ratio at about 12.3x. That marks a change from mid-September, when Arkham showed 39,800 ETH, 569 BTC, and 88,000 HYPE. Since then, he has trimmed his ETH and BTC longs and nearly doubled his HYPE position. 12 Wins Inside a $22.8 Million Hole Machi Big Brother, whose real name is Jeffrey Huang, trades on Hyperliquid with large leveraged positions. In March, BeInCrypto reported he had lost around $75 million there over the prior 6 months. Lookonchain counted 335 liquidations on his account by that point, earning him the nickname King of Liquidations.Hyperbot now puts his all-time perpetuals loss at $22.83 million. Including spot trading, the deficit widens to $24.48 million. His open positions currently carry about $2.2 million in unrealized profit. Against a $22.8 million deficit, the bigger swing factor remains his $131.24 million in ETH and BTC longs. Read the article at BeInCrypto

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

05:37 PM EDT, 10/05/2026 (MT Newswires) -- Allegion (ALLE) said late Monday it has acquired privately held Overly Door Company, a manufacturer of custom specialty doors for acoustic, blast, bullet-resistant and vault security. Overly, based in Greensburg, Pennsylvania, will operate as part of the Allegion Americas segment, it said. Terms of the transaction weren't disclosed.

MT newswire•2026/10/05 21:37

Updated Version 3 - According to the Financial Times, McKesson and CD&R are close to reaching a deal worth more than $5 billion to acquire Option Care.

In the fifth paragraph, a quote from analyst Sahil Pandey was added. Reuters, October 5 - According to the Financial Times, citing informed sources, pharmaceutical distributor McKesson (MCK.N) and private equity firm Clayton Dubilier & Rice are about to reach an acquisition agreement to purchase infusion service provider Option Care Health, with the deal valued (including debt) at over 5 billions USD. After the report was published, Option Care's share price rose by 21% in after-hours trading. The report stated that the deal could be announced as early as Tuesday, but negotiations could still fall through. This potential acquisition would be McKesson’s latest move in expanding its healthcare services portfolio. In August this year, the company agreed to acquire Precision Medicine Group for about 2.25 billions USD (link), as part of its effort over the years to strengthen high-growth business sectors. Leerink Partners analyst Michael Cherny said the “strategic logic” of the deal makes sense, as it would expand McKesson’s business from physician offices to care settings in the home and alternative sites. Option Care provides infusion services that allow patients to receive intravenous treatments at home or other outpatient settings, eliminating the need to go to the hospital. McKesson has previously been restructuring its business portfolio by divesting non-core assets and investing in fields such as oncology and specialty care (link). Driven by the growth of its specialty distribution business and contributions from acquisitions, revenue for its oncology and multi-specialty business segment grew by 33% in the latest fiscal quarter. McKesson declined to comment, while CD&R and Option Care did not immediately respond to Reuters’ requests for comment regarding the report. (For non-English speakers' convenience, Reuters offers automated machine translations of its reports in several languages. As there may be mistakes in the automated translations or some context may not be included, Reuters does not guarantee the accuracy of the automated translation text, which is provided solely for readers’ convenience. Reuters bears no responsibility for any damages or losses caused by the use of automated translation functions.)

路透社•2026/10/05 21:18